The clinical effectiveness and cost-effectiveness of pioglitazone for type 2 diabetes mellitus: a rapid and systematic review

The clinical effectiveness and cost-effectiveness of pioglitazone for type 2 diabetes mellitus: a rapid and systematic review

Bibliographic Details
Main Authors: J. Chilcott, J. Wight, M. Lloyd Jones, P. Tappenden
Format: Article
Language:English
Published: NIHR Journals Library 2001-01-01
Series:Health Technology Assessment
Online Access:https://doi.org/10.3310/hta5190
id doaj-bf3ddcebe7c4452ca0d836cbbbf7c51a
record_format Article
spelling doaj-bf3ddcebe7c4452ca0d836cbbbf7c51a2020-11-24T23:40:14ZengNIHR Journals LibraryHealth Technology Assessment1366-52782001-01-0151910.3310/hta5190The clinical effectiveness and cost-effectiveness of pioglitazone for type 2 diabetes mellitus: a rapid and systematic reviewJ. Chilcott0J. Wight1M. Lloyd Jones2P. Tappenden3University of Sheffield School of Health and Related Research, UKUniversity of Sheffield School of Health and Related Research, UKUniversity of Sheffield School of Health and Related Research, UKUniversity of Sheffield School of Health and Related Research, UKhttps://doi.org/10.3310/hta5190
collection DOAJ
language English
format Article
sources DOAJ
author J. Chilcott
J. Wight
M. Lloyd Jones
P. Tappenden
spellingShingle J. Chilcott
J. Wight
M. Lloyd Jones
P. Tappenden
The clinical effectiveness and cost-effectiveness of pioglitazone for type 2 diabetes mellitus: a rapid and systematic review
Health Technology Assessment
author_facet J. Chilcott
J. Wight
M. Lloyd Jones
P. Tappenden
author_sort J. Chilcott
title The clinical effectiveness and cost-effectiveness of pioglitazone for type 2 diabetes mellitus: a rapid and systematic review
title_short The clinical effectiveness and cost-effectiveness of pioglitazone for type 2 diabetes mellitus: a rapid and systematic review
title_full The clinical effectiveness and cost-effectiveness of pioglitazone for type 2 diabetes mellitus: a rapid and systematic review
title_fullStr The clinical effectiveness and cost-effectiveness of pioglitazone for type 2 diabetes mellitus: a rapid and systematic review
title_full_unstemmed The clinical effectiveness and cost-effectiveness of pioglitazone for type 2 diabetes mellitus: a rapid and systematic review
title_sort clinical effectiveness and cost-effectiveness of pioglitazone for type 2 diabetes mellitus: a rapid and systematic review
publisher NIHR Journals Library
series Health Technology Assessment
issn 1366-5278
publishDate 2001-01-01
url https://doi.org/10.3310/hta5190
work_keys_str_mv AT jchilcott theclinicaleffectivenessandcosteffectivenessofpioglitazonefortype2diabetesmellitusarapidandsystematicreview
AT jwight theclinicaleffectivenessandcosteffectivenessofpioglitazonefortype2diabetesmellitusarapidandsystematicreview
AT mlloydjones theclinicaleffectivenessandcosteffectivenessofpioglitazonefortype2diabetesmellitusarapidandsystematicreview
AT ptappenden theclinicaleffectivenessandcosteffectivenessofpioglitazonefortype2diabetesmellitusarapidandsystematicreview
AT jchilcott clinicaleffectivenessandcosteffectivenessofpioglitazonefortype2diabetesmellitusarapidandsystematicreview
AT jwight clinicaleffectivenessandcosteffectivenessofpioglitazonefortype2diabetesmellitusarapidandsystematicreview
AT mlloydjones clinicaleffectivenessandcosteffectivenessofpioglitazonefortype2diabetesmellitusarapidandsystematicreview
AT ptappenden clinicaleffectivenessandcosteffectivenessofpioglitazonefortype2diabetesmellitusarapidandsystematicreview
_version_ 1725510477835927552

Similar Items